Evidence map›Paper›PMID 42244100›Full record

ArticleThe Journal of dermatology2026

Predictors of Immunosuppressive Treatment in Cutaneous Arteritis: Analysis of Clinical Characteristics in 42 Patients.

Haruka Arakawa, Tomoya Watanabe, Yasushi Ototake, Saya Imai, Hisho Kawamura, Izumi Moteki, Asami Akita, Miwa Kanaoka, Miyu Kobayashi, Yusuke Saigusa and 1 more

Abstract read
In one paragraph

Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haruka ArakawaDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID https://orcid.org/0009-0001-9044-788X
Tomoya WatanabeDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID https://orcid.org/0000-0002-6654-6175
Yasushi OtotakeDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID https://orcid.org/0000-0001-6924-2823
Saya ImaiDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hisho KawamuraDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Izumi MotekiDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Asami AkitaDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Miwa KanaokaDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID https://orcid.org/0000-0001-6766-2242
Miyu KobayashiDepartment of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
Yusuke SaigusaDepartment of Biostatistics, Yokohama City University School of Medicine, Yokohama, Japan.
Yukie YamaguchiDepartment of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.ORCID https://orcid.org/0000-0002-0297-6627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous arteritis is a necrotizing vasculitis of medium-sized vessels in the skin for which no established criteria exist to guide the initiation of systemic treatment. This study aimed to identify the clinical and laboratory markers associated with the initiation of immunosuppressive treatments, including systemic corticosteroids. This retrospective chart review included 42 patients with cutaneous arteritis treated at the Department of Dermatology, Yokohama City University Hospital, from 2010 to 2023. Clinical manifestations and laboratory and imaging data were collected. Univariable and multivariable analyses were performed to identify the risk factors associated with the initiation of immunosuppressive treatment. Twenty-five patients with cutaneous arteritis (five men, 20 women) were included in this study. Of these, 14 patients received systemic corticosteroids and 11 were treated with additional immunosuppressive drugs. The Youden index analysis indicated that the thresholds of systemic corticosteroid induction were patients older than 43 years and platelet counts more than 340 000/μL. Univariable Firth logistic regression analysis showed numbness in the lower limbs, older age at onset, elevated platelet counts, and D-dimer levels (≥ 1 μg/mL) as risk factors for systemic corticosteroids. Our analysis identified several risk factors, such as numbness in the lower limbs, that may help predict the need for immunosuppressive treatment. Further large-scale prospective studies are required to confirm these findings.

Indexed as

Adrenal Cortex HormonesArteritisImmunosuppressive AgentsSkin Diseases, VascularAdultAgedAged, 80 and overAge FactorsFemaleFibrin Fibrinogen Degradation ProductsHumansMaleMiddle AgedPlatelet CountRetrospective StudiesRisk FactorsAdrenal Cortex HormonesFibrin Fibrinogen Degradation Productsfibrin fragment DImmunosuppressive Agentscohort studycutaneous arteritisimmunosuppressive therapyJapantreatment outcomes

Identifiers

PMID42244100
PMCPMC13435140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.